Andrew R Robbins's Net Worth

$9.9 Million

Estimate Recalculated Sep 8, 2024 07:31PM EST

Who is Andrew R Robbins?

Andrew R Robbins has an estimated net worth of $9.9 Million. This is based on reported shares across multiple companies, which include Cogent Biosciences, Inc., Harpoon Therapeutics, Inc., TURMERIC ACQUISITION CORP., and ARRAY BIOPHARMA INC.

SEC CIK

Andrew R Robbins's CIK is 0001590157

Past Insider Trading and Trends

2017 was Andrew R Robbins's most active year for acquiring shares with 8 total transactions. Andrew R Robbins's most active month to acquire stocks was the month of November. 2019 was Andrew R Robbins's most active year for disposing of shares, totalling 14 transactions. Andrew R Robbins's most active month to dispose stocks was the month of November. 2022 saw Andrew R Robbins paying a total of $3,410,808.00 for 700,167 shares, this is the most they've acquired in one year. In 2019 Andrew R Robbins cashed out on 2,044,527 shares for a total of $8,420,602.65, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Cogent Biosciences, Inc. (COGT) Snapshot price: $10.47

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 23
Form 4
—
0
—
—
0
Feb 13
Form 4
—
0
—
—
0
Jan 25
Form 4
—
0
—
—
0
Feb 10
Form 4
—
0
—
—
0
Dec 7
Form 4
—
0
—
—
0
Oct 23
Form 3
—
0
—
—
0
No matching records found

Harpoon Therapeutics, Inc. (HARP) No price found

Investor

Andrew R Robbins used to own units in Common Stock but no longer holds any shares there. From 2020 to 2024 Andrew R Robbins acquired a total of 5,000 shares in Harpoon Therapeutics, Inc., Andrew also disposed a total of 5,000 shares of Harpoon Therapeutics, Inc..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-5.00K
—
—
0
Mar 11
Form 4
∞
5K
—
—
5K
Nov 27
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 22
Form 4/A
—
0
—
—
0
May 4
Form 4
—
0
—
—
0
May 4
Form 4
—
0
—
—
0
Mar 30
Form 3
—
0
—
—
0
No matching records found

TURMERIC ACQUISITION CORP. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

ARRAY BIOPHARMA INC No price found

COO

Andrew R Robbins used to own units in Common Stock but no longer holds any shares there. From 2017 to 2019 Andrew R Robbins acquired a total of 705,520 shares in ARRAY BIOPHARMA INC at a cost of $2,941,119.24, Andrew also disposed a total of 842,355 shares of ARRAY BIOPHARMA INC equalling to $12,840,590.51.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-201.56K
$48.00
—
0
Jul 30
Form 4
+18.38%
11.03K
$24.60
-$213,036.00
71.02K
Apr 1
Form 4
-65.64%
-114.63K
$12.86
-$4,085,885.65
59.99K
Feb 6
Form 4
+9.50%
15.15K
$15.97
-$190,011.06
174.62K
Dec 14 - Dec 16
Form 4
—
0
$18.07
-$579,605.36
159.47K
Scheduled
Jun 27
Form 4
+0.74%
1.17K
$16.32
-$141,576.00
159.47K
Apr 1
Form 4
+331.52%
121.61K
$7.84
-$1,125,730.76
158.3K
Scheduled
Dec 16 - Dec 18
Form 4/A
-19.99%
-9.17K
$8.94
-$81,952.98
36.68K
Apr 1
Form 4
+9.86%
3.55K
$8.94
-$56,259.42
39.56K
Apr 1
Form 4
—
0
—
—
0
Dec 27
Form 4
-8.55%
-3.37K
$3.00
-$10,101.00
36.01K
Apr 1
Form 4
∞
39.38K
—
—
39.38K
Mar 2 - Apr 1
Form 4
—
0
$8.06
-$6,257.04
0
Mar 1 - Mar 2
Form 4
—
0
—
—
0
Aug 18
Form 4
—
0
—
—
0
Apr 1
Form 3
—
0
—
—
0
No matching records found